Dr. Gillian Stephany Friedman, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2080 S. E Street, San Bernandino, CA 92408 Phone: 909-388-9191 Fax: 909-388-9195 |
News Archive
Sweet news for those looking for new antibiotics: A new research published in the July 2010 print edition of the FASEB Journal explains for the first time how honey kills bacteria. Specifically, the research shows that bees make a protein that they add to the honey, called defensin-1, which could one day be used to treat burns and skin infections and to develop new drugs that could combat antibiotic-resistant infections.
Exposure to trihalomethanes in residential water is not associated with an increased risk of breast cancer. This is the main conclusion of a new study by the Barcelona Institute for Global Health, a center supported by the "la Caixa" Banking Foundation.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
Among the 118 patients with portal vein thrombosis, noncirrhotic and nontumoral extrahepatic portal vein obstruction are young and present with well tolerated bleed.
› Verified 9 days ago